Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, ...

The research, titled "Identifying Allosteric Hotspots in Mycobacterium tuberculosis cAMP Receptor Protein through Structural Homology," was led by Dr. Rodrigo Maillard at Georgetown University ...

The orally administered, brain-penetrant small molecule is an allosteric protein modulator that restores the function of the lysosomal protein enzyme glucocerebrosidase (GCase) which becomes ...

The orally administered, brain-penetrant small molecule is an allosteric protein modulator that restores the function of the lysosomal protein enzyme glucocerebrosidase (GCase) which becomes misfolded ...

Rapport Therapeutics to showcase data at 2025 American Academy of Neurology Annual Meeting in San Diego from April 5-9, 2025: San Diego Tuesday, March 25, 2025, 14:00 Hrs [IST] Ra ...